Source · study

Topical nicotinamide for seborrheic dermatitis: an open randomized study

Primary source

Publisher:: Journal of Dermatological Treatment (Fabbrocini G, 2014)
Source type:: Journal · study
Last checked:: 2026-11-10
URL:: https://doi.org/10.3109/09546634.2013.814754

Pages that cite it

Evidence: In an open randomized, vehicle-controlled trial of 48 people with mild-to-moderate facial seborrheic dermatitis, 4% nicotinamide cream once daily for 12 weeks reduced the combined erythema/scaling/infiltration score by 75% from baseline versus 35% with the vehicle (p<0.05).